It helps generate brain chemicals called neurotransmitters, including dopamine, epinephrine, and norepinephrine. It shows ...

My 32-year-old daughter was recently diagnosed with chronic myeloid leukemia. It's a lot to take in. We've heard about ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Sumit Sharma, MD, sat down with Sydney Crago of Modern Retina to discuss his presentation on the 3 tyrosine kinase inhibitors ...

I highlight potential of Biomea Fusion's diabetes drug amid competition, advises caution with stock due to risks. Read more ...

Researchers leading the SWOG S1712 clinical trial have found that adding ruxolitinib to standard tyrosine kinase inhibitor ...

For the first time, HonorHealth Research Institute is offering a promising clinical trial for patients with specific types of ...

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on BridgeBio Pharma (BBIO – Research Report) today and set a price target ...

A new artificial intelligence model developed by researchers at The University of Texas at Austin paves the way for more ...

Analyst Kostas Biliouris of BMO Capital maintained a Hold rating on BridgeBio Pharma (BBIO – Research Report), retaining the price target ...

Researchers from Deakin University reveal how yoyo dieting disrupts gut health, leading to weight regain and obesity-related ...